Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain



The incidence of obesity and overweight in the US has increased considerably during the past two decades and currently affects 65% of the adult population. Research has indicated that small, yet irreversible, gains during the holiday season contribute to increases in weight during adulthood. Conjugated linoleic acid (CLA), a naturally occurring dietary fatty acid, has been found to reduce weight gain and dramatically decrease fat mass in animals. Although research in humans has shown inconsistent results, most studies have been of insufficient duration or have utilized body composition methods that are less accurate than the currently accepted criterion.


Randomized, double-blind, placebo-controlled study of 3.2 g/day CLA for 6 months.


Forty healthy, overweight subjects (age: 18–44 years; body mass index: 25–30 kg/m2)


Body composition by the four-compartment model, resting metabolic rate (RMR) by indirect calorimetry, self-reported physical activity and dietary intake, and blood chemistries were determined at baseline and after 6 months. Body weight was measured monthly during the pre-holiday season (August–October), holiday season (November–December) and post-holiday season (January–March). Adverse events were assessed monthly.


Compared to CLA, the placebo group showed a greater rate of weight gain during the holiday season (P=0.01). Within the placebo group, holiday weight change was significantly greater compared to the pre-holiday period (August–October) (P=0.03). Six-month change in body composition was improved with CLA compared to placebo (P=0.02), and body fat was significantly reduced within the CLA group (−1.0±2.2 kg, P=0.05). CLA had no effect on RMR, physical activity or dietary intake. The rate of reported negative emotions decreased significantly with CLA, although there was no difference in any other category of adverse event. In comparison to the placebo, CLA did not affect insulin resistance, blood lipids and markers of liver function or markers of inflammation, with the exception of a significant decrease in a biomarker of endothelial dysfunction.


CLA supplementation among overweight adults significantly reduced body fat over 6 months and prevented weight gain during the holiday season. Although no adverse effects were seen, additional studies should evaluate the effect of prolonged use of CLA.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1


  1. δ(permil)=((Runknown−Rstandard)/Rstandard)×1000, where R is the ratio of the abundance of heavy isotope to that of the light isotope.


  1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM . Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291: 2847–2850.

    Article  CAS  Google Scholar 

  2. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68: 899–917.

  3. Pariza MW . Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004; 79: 1132S–1136S.

    Article  CAS  Google Scholar 

  4. Wang YW, Jones PJ . Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004; 28: 941–955.

    Article  CAS  Google Scholar 

  5. Terpstra AH . Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am J Clin Nutr 2004; 79: 352–361.

    Article  CAS  Google Scholar 

  6. Wahle KW, Heys SD, Rotondo D . Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 2004; 43: 553–587.

    Article  CAS  Google Scholar 

  7. Atkinson RL . Conjugated linoleic acid for altering body composition and treating obesity. Advances in conjugated linoleic acid research, volume 1. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ (eds). AOCS Press: Champagne, IL, 1999. pp. 348–353.

  8. Berven G, Bye A, Hals O . Safety of conjugated linoleic acid (CLA) in overweight or obese volunteers. Eur J Lipid Sci Technol 2000; 102: 455–462.

    Article  CAS  Google Scholar 

  9. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O . Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000; 130: 2943–2948.

    Article  CAS  Google Scholar 

  10. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005; 135: 778–784.

    Article  CAS  Google Scholar 

  11. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004; 79: 1118–1125.

    Article  CAS  Google Scholar 

  12. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS . The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003; 27: 840–847.

    Article  CAS  Google Scholar 

  13. Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL . Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 2004; 42: 1701–1709.

    Article  CAS  Google Scholar 

  14. Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O'Neil PM, Sebring NG . A prospective study of holiday weight gain. N Engl J Med 2000; 342: 861–867.

    Article  CAS  Google Scholar 

  15. Bartok-Olson CJ, Schoeller DA, Sullivan JC, Clark RR . The ‘B’ in the Selinger Four-Compartment body composition formula should be body mineral instead of bone mineral. Ann NY Acad Sci 2000; 904: 342–344.

    Article  CAS  Google Scholar 

  16. Behnke A, Wilmore J . Evaluation and Regulation of Body Build and Composition. Prentice-Hall: Englewood Cliffs, NJ, 1974.

    Google Scholar 

  17. Wilmore H . A simplified method for determination of residual lung volumes. J Appl Physiol 1969; 27: 98–100.

    Google Scholar 

  18. Schoeller D, Luke A . Rapid 18O analysis of CO2 samples by continuous-flow isotope ratio mass spectrometry. J Mass Spec 1997; 32: 1332–1336.

    Article  CAS  Google Scholar 

  19. Schoeller D . Hydrometry. In: Heymsfield S, Lohman T, Wang Z, Going S (eds). Human Body Composition. Human Kinetics: Champagne, IL, 2005. pp 35–49.

    Google Scholar 

  20. Heymsfield S, Lichtman S, Baumgartner R, Wang J, Kamen Y, Aliprantis A et al. Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr 1990; 52: 52–58.

    Article  CAS  Google Scholar 

  21. Weir JB . New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1–9.

    Article  Google Scholar 

  22. Sallis J . Seven day physical activity recall. Med Sci Sports Exerc 1997; 29: S89–S103.

    Google Scholar 

  23. Conwell LS, Trost SG, Brown WJ, Batch JA . Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004; 27: 314–319.

    Article  Google Scholar 

  24. Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie YG et al. Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr 2005; 81: 74–78.

    Article  CAS  Google Scholar 

  25. Larsen TM, Toubro S, Astrup A . Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003; 44: 2234–2241.

    Article  CAS  Google Scholar 

  26. Riserus U, Arner P, Brismar K, Vessby B . Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25: 1516–1521.

    Article  CAS  Google Scholar 

  27. Eyjolfson V, Spriet LL, Dyck DJ . Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc 2004; 36: 814–820.

    Article  CAS  Google Scholar 

  28. Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 2004; 80: 257–263.

    Article  CAS  Google Scholar 

  29. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 2004; 12: 591–598.

    Article  CAS  Google Scholar 

  30. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135: 562–566.

    Article  CAS  Google Scholar 

  31. Smedman A, Vessby B . Conjugated linoleic acid supplementation in humans – metabolic effects. Lipids 2001; 36: 773–781.

    Article  CAS  Google Scholar 

  32. Schulz LO, Schoeller DA . A compilation of total daily energy expenditures and body weights in healthy adults. Am J Clin Nutr 1994; 60: 676–681.

    Article  CAS  Google Scholar 

  33. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003; 158: 1–13.

    Article  Google Scholar 

Download references


We thank Randall Clark and Jude Sullivan of the University of Wisconsin Hospitals and Clinics Exercise Science Laboratory for conducting body composition analysis; The University of Wisconsin General Clinical Research Center for providing in-patient support and dietary analysis; and Dr Earl Shrago for completing subject medical history and physical examinations. We acknowledge Cognis Nutrition and Health for providing test materials and sponsorship.

ACW contributed to study design, recruited subjects, completed data collection, contributed to data interpretation and wrote the manuscript. ACB contributed to study design and revised the manuscript. RNC assisted with data collection and ZZ provided assistance with statistical analysis. DAS established the study design, obtained study funding, interpreted data and revised the manuscript. None of the authors had or have any financial or personal interest in the sponsor of this research.

Author information

Authors and Affiliations


Corresponding author

Correspondence to D A Schoeller.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Watras, A., Buchholz, A., Close, R. et al. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes 31, 481–487 (2007).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • CLA
  • body composition
  • four-compartment model
  • body weight
  • overweight

This article is cited by


Quick links